 |
|
No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression
Alessandro Serretti, Chiara Fabbri, Silvia Pellegrini, Stefano Porcelli, Pierluigi Politi, Silvio Bellino, Marco Menchetti, Veronica Mariotti, Cristina Demi, Valentina Martinelli, Marco Cappucciati, Paola Bozzatello, Elena Brignolo, Paolo Brambilla, Chi-Un Pae, Matteo Balestrieri, Diana De Ronchi
Psychiatry Investig. 2013;10(2):180-189. Published online 2013 May 30 DOI: https://doi.org/10.4306/pi.2013.10.2.180
|
|
Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia
Estela Sangüesa, Emilio Fernández-Egea, Julia Concha, Cristina B. García, María Pilar Ribate
Biomedicines.2024; 12(3): 597. CrossRef MTHFR, NR3C1, FKBP5, and CRHR1 gene polymorphisms are strongly associated with depressive disorder susceptibility: A meta-analysis and power analysis
Vajagathali Mohammed, Meenakshi Shanmugaraja, Ranjith Balakrishnan
Human Gene.2023; 38: 201233. CrossRef Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis
Yuan-sheng Wan, Xue-jia Zhai, Hong-ai Tan, You-sheng Ai, Li-bo Zhao
The Pharmacogenomics Journal.2021; 21(2): 200. CrossRef Association between COMT gene Val108/158Met and antidepressive treatment response: A meta-analysis
Zhen Tang, Shumin Zhang, Dongmei Guo, Hanyan Wang
Gene.2020; 734: 144333. CrossRef Association Between Genetic Polymorphism and Antidepressants in Major Depression: A Network Meta-Analysis
Dan Du, Qiong Tang, Qiong Han, Jin Zhang, Xuemei Liang, Youguo Tan, Kezhi Liu, Bo Xiang
Pharmacogenomics.2020; 21(13): 963. CrossRef Genetic variants in major depressive disorder: From pathophysiology to therapy
Xenia Gonda, Peter Petschner, Nora Eszlari, Daniel Baksa, Andrea Edes, Peter Antal, Gabriella Juhasz, Gyorgy Bagdy
Pharmacology & Therapeutics.2019; 194: 22. CrossRef Implementation of Pharmacogenetics in a Clozapine Treatment Resistant Patient: A Case Report
Estela Sangüesa, Christine Cirujeda, Julia Concha, Pedro Pablo Padilla, María Pilar Ribate, Cristina Belén García
Pharmacogenomics.2019; 20(12): 871. CrossRef Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
Bharathi S. Gadad, Manish K. Jha, Andrew Czysz, Jennifer L. Furman, Taryn L. Mayes, Michael P. Emslie, Madhukar H. Trivedi
Journal of Affective Disorders.2018; 233: 3. CrossRef Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years
G. Voegeli, M. L. Cléry-Melin, N. Ramoz, P. Gorwood
Drugs.2017; 77(18): 1967. CrossRef Exposure to pesticide as a risk factor for depression: A population-based longitudinal study in Korea
Sang-Baek Koh, Tae Hui Kim, Seongho Min, Kyungsuk Lee, Dae Ryong Kang, Jung Ran Choi
NeuroToxicology.2017; 62: 181. CrossRef Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies
Tristram A. Lett, Henrik Walter, Eva J. Brandl
CNS Drugs.2016; 30(12): 1169. CrossRef Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
Gaël Qesseveur, Anne Cécile Petit, Hai Thanh Nguyen, Lionel Dahan, Romain Colle, Samuel Rotenberg, Isabelle Seif, Pauline Robert, Denis David, Jean-Philippe Guilloux, Alain M. Gardier, Céline Verstuyft, Laurent Becquemont, Emmanuelle Corruble, Bruno P. Gu
Neuropharmacology.2016; 105: 142. CrossRef Pharmacogenetic studies: a tool to improve antidepressant therapy
Marta Ramos, Cecilia Berrogain, Julia Concha, Laura Lomba, Cristina Belén García, Mª Pilar Ribate
Drug Metabolism and Personalized Therapy.2016; 31(4): 197. CrossRef Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety Disorders
Sarah G Helton, Falk W Lohoff
Pharmacogenomics.2015; 16(5): 541. CrossRef Are there meaningful biomarkers of treatment response for depression?
Barbara Breitenstein, Sandra Scheuer, Florian Holsboer
Drug Discovery Today.2014; 19(5): 539. CrossRef Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder
Yoshihiko Matsumoto, Chiara Fabbri, Silvia Pellegrini, Stefano Porcelli, Pierluigi Politi, Silvio Bellino, Caterina Iofrida, Veronica Mariotti, Erika Melissari, Marco Menchetti, Valentina Martinelli, Marco Cappucciati, Paola Bozzatello, Elena Brignolo, Pa
Molecular Diagnosis & Therapy.2014; 18(5): 567. CrossRef Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis
Jian-Yang Lin, Ming-Yan Jiang, Zhou-Mi Kan, Yang Chu
Journal of Affective Disorders.2014; 168: 430. CrossRef
|